Red blood cells (RBCs) and RBC membrane-derived nanoparticles have been historically
developed as bioinspired drug delivery systems to combat the issues of premature …

Nanoparticle‐based therapeutic, prevention, and detection modalities have the potential to
greatly impact how diseases are diagnosed and managed in the clinic. With the wide range …

An active cell membrane–camouflaged nanoparticle, owning to membrane antigens and
membrane structure, can achieve special properties such as specific recognition, long blood …

Cell‐membrane‐coated nanoparticles have recently been studied extensively for their
biological compatibility, retention of cellular properties, and adaptability to a variety of …

Robust electrochemiluminescence (ECL) of carbon nitride (CN) requires efficient electron‐
hole recombination and the suppression of electrode passivation. In this work, Au …

Cell membrane coating has emerged as an intriguing biomimetic strategy to endow
nanomaterials with functions and properties inherent to source cells for various biomedical …

Sepsis, resulting from uncontrolled inflammatory responses to bacterial infections, continues
to cause high morbidity and mortality worldwide. Currently, effective sepsis treatments are …

The safe and efficient delivery of chemotherapeutic agents remains critical to anticancer
therapy. Herein, we report on a targeted drug delivery system based upon a modified cell …

The continued evolution of biomedical nanotechnology has enabled clinicians to better
detect, prevent, manage, and treat human disease. In order to further push the limits of …

Surface modification of nanomaterials is essential for their biomedical applications owing to
their passive immune clearance and damage to reticuloendothelial systems. Recently, a cell …